Frequency of somatic TP53 mutations in non-small cell lung cancer in Kazakhstan

被引：0
|
作者：
Zhuraliyeva, A. [1 ]
Wang, J. [2 ]
Khamdiyeva, O. [1 ]
Abdullaev, Z. [2 ]
Pack, S. [2 ]
Biyasheva, Z. [1 ]
机构：
[1] Al Farabi Kazakh Natl Univ, Sci Res Inst Issues Biol & Biotechnol, Alma Ata, Kazakhstan
[2] NCI, Pathol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
FEBS OPEN BIO | 2019年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-35-114
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [41] Involvement of TP53 and TP16 expression in human papillomavirus-associated non-small cell lung cancer
    Li, Ming
    Zhang, Xiao-Lei
    Deng, Fang
    Qian, Li-Ting
    Meng, Shui-Ping
    Shan, Wu-Lin
    Wang, Bao-Long
    ONCOLOGY LETTERS, 2016, 12 (05) : 3330 - 3336
  • [42] Non-invasive detection of EGFR and TP53 mutations through the combination of plasma, urine and sputum in advanced non-small cell lung cancer
    Wu, Zhen
    Yang, Zhen
    Li, Chun-Sun
    Zhao, Wei
    Liang, Zhi-Xin
    Dai, Yu
    Zeng, Jing
    Zhu, Qiang
    Miao, Kai-Ling
    Cui, Dong-Hua
    Chen, Liang-An
    ONCOLOGY LETTERS, 2019, 18 (04) : 3581 - 3590
  • [43] Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC)
    Feng, J.
    Hueniken, K.
    Fan, Z. J.
    Corke, L.
    Leighl, N. B.
    Liu, G.
    Bradbury, P. A.
    Sacher, A.
    Eng, L.
    Stockley, T.
    Tsao, M. S.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S343 - S344
  • [44] Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
    Zhao, Jiayi
    Han, Yiping
    Li, Jiamei
    Chai, Rong
    Bai, Chong
    ONCOLOGY LETTERS, 2019, 17 (03) : 3233 - 3240
  • [45] TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
    Liu, Surui
    Yu, Jin
    Zhang, Hui
    Liu, Jie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer TP53 mutations
    Fukuda, Koji
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Sato, Shigeki
    Kotani, Hiroshi
    Kita, Kenji
    Nishiyama, Akihiro
    Sakaguchi, Hiroyuki
    Ohtsubo, Koshiro
    Yano, Seiji
    CELL REPORTS MEDICINE, 2024, 5 (06)
  • [47] TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Citarella, F.
    Russano, M.
    Fiorenti, M.
    La Cava, G.
    Pizzutilo, E. G.
    Martinelli, F.
    Pierri, S.
    Russo, A.
    Muscolino, P.
    Sapuppo, E.
    Marinello, A.
    Aldea, M.
    Besse, B.
    Filetti, M.
    Lombardi, P.
    Vitale, A.
    Buzzacchino, F.
    Cristofani, L.
    Lugini, A.
    Cortellini, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S848 - S848
  • [48] The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer
    Zhang, YuXuan
    Shen, Yuhong
    Wu, Jiayuan
    Zhang, Jun
    Cao, Chenxi
    Mo, Juanfen
    Bao, Yi
    ONCOTARGETS AND THERAPY, 2024, 17 : 755 - 763
  • [49] Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
    Canale, Matteo
    Petracci, Elisabetta
    Cravero, Paola
    Mariotti, Marita
    Minuti, Gabriele
    Metro, Giulio
    Ludovini, Vienna
    Baglivo, Sara
    Puccetti, Maurizio
    Dubini, Alessandra
    Martinelli, Giovanni
    Delmonte, Angelo
    Crino, Lucio
    Ulivi, Paola
    TRANSLATIONAL ONCOLOGY, 2022, 23
  • [50] Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer
    Tomasini, Pascale
    Mascaux, Celine
    Jao, Kevin
    Labbe, Catherine
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Hwang, David M.
    Leighl, Natasha B.
    Liu, Geoffrey
    Bradbury, Penelope A.
    Pintilie, Melania
    Tsao, Ming-Sound
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2019, 20 (03) : E338 - E345
12345